Figure 5.
In vivo Chol distribution (A) and luciferase expression (B) of Lipo 2000/pGL-3, CPL/pGL-3, and EGF-CPL/pGL-3 complexes 3 days after administration to tumour-bearing nude mice via tail vein injection.
In vivo Chol distribution (A) and luciferase expression (B) of Lipo 2000/pGL-3, CPL/pGL-3, and EGF-CPL/pGL-3 complexes 3 days after administration to tumour-bearing nude mice via tail vein injection.